Literature DB >> 11249857

Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression.

C W Heilig1, J I Kreisberg, S Freytag, T Murakami, Y Ebina, L Guo, K Heilig, R Loberg, X Qu, Y Jin, D Henry, F C Brosius.   

Abstract

A stable clone of rat mesangial cells expressing antisense GLUT-1 (i.e., MCGT1AS cells) was developed to protect them from high glucose exposure. GLUT-1 protein was reduced 50%, and the 2-deoxy-[(3)H]glucose uptake rate was reduced 33% in MCGT1AS. MCLacZ control cells and MCGT1 GLUT-1-overexpressing cells were used for comparisons. In MCLacZ, 20 mM D-glucose increased GLUT-1 transcription 90% vs. no increase in MCGT1AS. Glucose (8 mM) and 12 mM xylitol [a hexose monophosphate (HMP) shunt substrate] did not stimulate GLUT-1 transcription. An 87% replacement of the standard 8 mM D-glucose with 3-O-methylglucose reduced GLUT-1 transcription 80%. D-Glucose (20 mM) increased fibronectin mRNA and protein by 47 and 100%, respectively, in MCLacZ vs. no increases in MCGT1AS. Fibronectin synthesis was elevated 48% in MCGT1 and reduced 44% in MCGT1AS. We conclude that 1) transcription of GLUT-1 in response to D-glucose depends on glucose metabolism, although not through the HMP shunt, and 2) antisense GLUT-1 treatment of mesangial cells blocks D-glucose-induced GLUT-1 and fibronectin expression, thereby demonstrating a protective effect that could be beneficial in the setting of diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11249857     DOI: 10.1152/ajprenal.2001.280.4.F657

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  14 in total

Review 1.  Glucose transporters in diabetic nephropathy.

Authors:  Frank C Brosius; Charles W Heilig
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.714

2.  GLUT1 enhances mTOR activity independently of TSC2 and AMPK.

Authors:  Carolyn L Buller; Charles W Heilig; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2011-05-25

3.  MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes.

Authors:  Nirmalya Dey; Falguni Das; Meenalakshmi M Mariappan; Chandi Charan Mandal; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

Review 4.  Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis.

Authors:  Wenpeng Cui; Bing Du; Wenhua Zhou; Ye Jia; Guangdong Sun; Jing Sun; Dongmei Zhang; Hang Yuan; Feng Xu; Xuehong Lu; Ping Luo; Lining Miao
Journal:  Mol Biol Rep       Date:  2012-06-17       Impact factor: 2.316

5.  Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.

Authors:  Youli Wang; Kathleen Heilig; Thomas Saunders; Andrew Minto; Dilip K Deb; Anthony Chang; Frank Brosius; Carmela Monteiro; Charles W Heilig
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-07

6.  Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.

Authors:  Hongyu Zhang; MaryLee Schin; Jharna Saha; Kathleen Burke; Lawrence B Holzman; Wanda Filipiak; Thomas Saunders; Minghui Xiang; Charles W Heilig; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-07

Review 7.  The link between Glut-1 and hypertension in diabetic nephropathy.

Authors:  Luigi Gnudi; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

8.  Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.

Authors:  Hongyu Zhang; Jharna Saha; Jaeman Byun; MaryLee Schin; Matthew Lorenz; Robert T Kennedy; Matthias Kretzler; Eva L Feldman; Subramaniam Pennathur; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30

9.  Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy.

Authors:  Charles W Heilig; Thomas Saunders; Frank C Brosius; Kelle Moley; Kathleen Heilig; Raymond Baggs; LiRong Guo; David Conner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

Review 10.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.